These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

146 related articles for article (PubMed ID: 7336095)

  • 21. [Biochemical and electronoptic study on the possible effect of silymarin on ethanol-induced liver damage in rats].
    Platt D; Schnorr B
    Arzneimittelforschung; 1971 Aug; 21(8):1206-8. PubMed ID: 5110020
    [No Abstract]   [Full Text] [Related]  

  • 22. [Effectiveness of legalon and essentiale in a tetracycline-induced liver lesion].
    Skakun NP; Stepanova NIu
    Antibiot Med Biotekhnol; 1986 Oct; 31(10):781-4. PubMed ID: 3789688
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Hepatoprotective activity of silymarin against hepatic damage in Mastomys natalensis infected with Plasmodium berghei.
    Chander R; Kapoor NK; Dhawan BN
    Indian J Med Res; 1989 Dec; 90():472-7. PubMed ID: 2697691
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Inhibition, by drugs, of galactosamine induced hepatitis in the rat.
    Pickering RW; Lynn James GW; Parker FL
    Arzneimittelforschung; 1975 Oct; 25(10):1591-2. PubMed ID: 1243044
    [TBL] [Abstract][Full Text] [Related]  

  • 25. [Therapy of hepatic diseases in ambulatory medicine. Multicenter studies].
    Martines G; Mingrino GC; Cagnetta G; Copponi V
    Clin Ter; 1980 Jan; 92(1):33-58. PubMed ID: 7449307
    [No Abstract]   [Full Text] [Related]  

  • 26. [The hepatoprotective and cholagogic action of glycyrrhizic acid derivatives].
    Nasyrov KhM; Chepurina LS; Kireeva RM
    Eksp Klin Farmakol; 1995; 58(6):60-3. PubMed ID: 8704617
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Structure of the liver after correction of experimental chronic hepatitis with benzonal and potassium orotate].
    Baĭbekova EM; Sultanova LI
    Arkh Anat Gistol Embriol; 1990 Feb; 98(2):88-94. PubMed ID: 2353891
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Toxic occupational liver diseases. Therapeutic effects of silymarin].
    Boari C; Montanari FM; Galletti GP; Rizzoli D; Baldi E; Caudarella R; Gennari P
    Minerva Med; 1981 Oct; 72(40):2679-88. PubMed ID: 7290471
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Silibinin: Madaus].
    Wien Klin Wochenschr; 1987 Jun; 99(13):471-4. PubMed ID: 3630178
    [No Abstract]   [Full Text] [Related]  

  • 30. [Silymarin in the prevention of hepatic damage by psychopharmacologic drugs. Experimental premises and clinical evaluations].
    Carrescia O; Benelli L; Saraceni F; Braga PC; Cagnetta G; Copponi V
    Clin Ter; 1980 Oct; 95(2):157-64. PubMed ID: 7471652
    [No Abstract]   [Full Text] [Related]  

  • 31. [Immunomodulator effect of silymarin therapy in chronic alcoholic liver diseases].
    Deák G; Müzes G; Láng I; Niederland V; Nékám K; Gonzalez-Cabello R; Gergely P; Fehér J
    Orv Hetil; 1990 Jun; 131(24):1291-2, 1295-6. PubMed ID: 2195425
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [The use of silymarin in patients with toxic and viral liver diseases].
    Matveev AV; Koniaeva EI
    Eksp Klin Gastroenterol; 2011; (5):84-90. PubMed ID: 21916240
    [TBL] [Abstract][Full Text] [Related]  

  • 33. [Effect of antihepatotoxic tea on the course of drug-induced hepatitis].
    Ubeeva IP; Nikolaev SM; Sambueva ZG
    Antibiot Khimioter; 1989 Nov; 34(11):859-62. PubMed ID: 2633705
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Constituents of Silybum marianum and their therapeutic use].
    Morelli I
    Boll Chim Farm; 1978 May; 117(5):258-67. PubMed ID: 743375
    [No Abstract]   [Full Text] [Related]  

  • 35. [Action of hepatoprotective agents in a tetracycline lesion of the liver].
    Porokhniak LA; Drogovoz SM; Rogozhin BA
    Antibiot Med Biotekhnol; 1987 Apr; 32(4):282-5. PubMed ID: 3631934
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Antihepatoxic effect of silymarin on the disordered phospholipid metabolism due to phalloidine intoxication in rats].
    Schriewer H; Rauen HM
    Hoppe Seylers Z Physiol Chem; 1972 Oct; 353(10):1567-8. PubMed ID: 4649836
    [No Abstract]   [Full Text] [Related]  

  • 37. Effect of partial hepatectomy on the hepatotoxicity of D-galactosamine.
    Andreicuţ S; Kerekes M
    Morphol Embryol (Bucur); 1982; 28(2):177-84. PubMed ID: 6213854
    [No Abstract]   [Full Text] [Related]  

  • 38. [Drug clinics. Drug of the month. Legalon (silymarin)].
    Luyckx F; Scheen AJ
    Rev Med Liege; 1997 Dec; 52(12):792-6. PubMed ID: 9481179
    [No Abstract]   [Full Text] [Related]  

  • 39. Galactosamine induced liver injury.
    Decker K; Keppler D
    Prog Liver Dis; 1972; 4():183-99. PubMed ID: 4631501
    [No Abstract]   [Full Text] [Related]  

  • 40. Hepatocurative effect of picroliv and silymarin against aflatoxin B1 induced hepatotoxicity in rats.
    Rastogi R; Srivastava AK; Srivastava M; Rastogi AK
    Planta Med; 2000 Dec; 66(8):709-13. PubMed ID: 11199126
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.